microRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer
Metrics: PDF 1111 views | HTML 1163 views | ?
Tung On Yau1, Chung Wah Wu1, Ceen-Ming Tang1,2, Yingxuan Chen3, Jingyuan Fang3, Yujuan Dong1,4, Qiaoyi Liang1, Simon Siu Man Ng4, Francis Ka Leung Chan1, Joseph Jao Yiu Sung1, Jun Yu1
1Institute of Digestive Disease and Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong
2Oxford University Clinical Academic Graduate School, John Radcliffe Hospital, Oxford, UK
3Renji Hospital, Shanghai Jiaotong University, Shanghai, China
4Department of Surgery, The Chinese University of Hong Kong, Hong Kong
Jun Yu, e-mail: email@example.com
Keywords: microRNA, non-invasive, stool biomarker, colorectal cancer, diagnosis
Received: July 25, 2015 Accepted: November 15, 2015 Published: November 26, 2015
Objective: Detection of microRNA (miRNA) aberrations in human faeces is a new approach for colorectal cancer (CRC) screening. The aim of this study was to characterise miR-20a in faeces as a non-invasive biomarker for diagnosis of CRC.
Results: miR-20a expression was significantly higher in the 40 CRC tumours compared to their respective adjacent normal tissues (P = 0.0065). Levels of miR-20a were also significantly higher in faecal samples from CRC patients (P < 0.0001). The area under receiver operating characteristic (AUROC) curve for miR-20a was 0.73, with a sensitivity of 55% and specificity of 82% for CRC patients compared with controls. No significant difference in the level of miR-20a was found between patients with proximal, distal, and rectal cancer. The use of antibiotics did not influence faecal miR-20a levels.
Patients and Methods: miR-20a was selected from an expression microarray containing 667 miRNAs. Further verification of miR-20a was performed in 40 pairs of primary CRC tissues, as well as 595 faecal samples (198 CRCs, 199 adenomas, and 198 healthy controls) using TaqMan probe based quantitative Real-Time PCR (qRT-PCR).
Conclusions: Faecal-based miR-20a can be utilised as a potential non-invasive biomarker for CRC screening.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.